Passage Bio, Inc. (PASG)
4.49
+0.05
(+1.13%)
USD |
NASDAQ |
Sep 02, 16:00
4.49
0.00 (0.00%)
After-Hours: 16:04
Passage Bio Net Income (TTM) : -36.11M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -36.11M |
| March 31, 2026 | -37.68M |
| December 31, 2025 | -45.52M |
| September 30, 2025 | -45.26M |
| June 30, 2025 | -56.86M |
| March 31, 2025 | -63.46M |
| December 31, 2024 | -64.77M |
| September 30, 2024 | -68.80M |
| June 30, 2024 | -76.57M |
| March 31, 2024 | -84.44M |
| December 31, 2023 | -102.06M |
| September 30, 2023 | -112.38M |
| June 30, 2023 | -111.97M |
| March 31, 2023 | -127.65M |
| Date | Value |
|---|---|
| December 31, 2022 | -136.12M |
| September 30, 2022 | -160.21M |
| June 30, 2022 | -180.42M |
| March 31, 2022 | -189.32M |
| December 31, 2021 | -185.39M |
| September 30, 2021 | -173.18M |
| June 30, 2021 | -154.79M |
| March 31, 2021 | -133.53M |
| December 31, 2020 | -112.23M |
| September 30, 2020 | -86.44M |
| June 30, 2020 | -69.30M |
| March 31, 2020 | -55.55M |
| December 31, 2019 | -45.63M |
| September 30, 2019 | -38.30M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| ARS Pharmaceuticals, Inc. | -215.43M |
| ACADIA Pharmaceuticals, Inc. | 380.48M |
| Alnylam Pharmaceuticals, Inc. | 807.99M |
| Anika Therapeutics, Inc. | -3.121M |
| Savara, Inc. | -139.31M |